Molecular Profiling in Advanced Non–Small Cell Lung Cancer: Navigating the New Treatment
Last Modified: February 25, 2016
Corey J. Langer, MD, FACP
Tracey L. Evans, MD
Beth Eaby-Sandy, MSN, CRNP, OCN
CME/CE Released: 02/24/2015; Valid for credit through 02/24/2016.
This activity was developed for a multidisciplinary audience that includes medical, surgical, and radiation oncologists, hematologists, pathologists, hematology/oncology fellows, oncology nurses, and other healthcare professionals involved in the treatment of patients with NSCLC.
The goal of this educational program is to provide an update on evidence-based therapeutic strategies in the individualized treatment of advanced NSCLC based on the results of molecular and genetic testing.
Upon completion of this activity, participants should be able to:
- Review evidence-based therapeutic strategies in the individualized treatment of advanced NSCLC
- Integrate molecular and genetic testing results in the treatment of NSCLC
- Discuss interdisciplinary care of patients with advanced NSCLC